TY - JOUR T1 - Challenges of evaluating lung function as part of cancer care during the COVID-19 pandemic JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01621-2020 VL - 56 IS - 2 SP - 2001621 AU - Justin L. Garner AU - Pallav L. Shah Y1 - 2020/08/01 UR - http://erj.ersjournals.com/content/56/2/2001621.abstract N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly identified agent foisted upon humanity and responsible for the contagious affliction, coronavirus disease 2019 (COVID-19) [1] that has rapidly evolved into a pandemic testing to the limits, and sometimes beyond, the capacity to respond of healthcare systems across the world [2]. Management is purely supportive and social isolation crucial to containment [3]. Enforced reallocation of hospital resources and personnel to cope with the increasing numbers requiring hospital admission and intensive care [4] in the most trying of conditions has been at the expense of many hospital departments, among them those offering diagnostic and support services for lung cancer [5–7].The COVID-19 pandemic and the necessity for social isolation are ushering in a new era of remote clinical evaluation. Modifications of CT imaging and processing in chest medicine yield both anatomical and functional information in a safe environment. https://bit.ly/2Np3Dyz ER -